Search Login Register
Nimodipine
(Modus)
Summary
Description:
A calcium channel blockader with preferential cerebrovascular activity. It has marked cerebrovascular dilating effects and lowers blood pressure.
Also Known As:
Modus; Admon; Nimotop; Almirall Brand of Nimodipine; Alpharma Brand of Nimodipine Show All >>
Networked: 1205
relevant articles (159 outcomes,
250 trials/studies)
for this Drug
Key Diseases for which Nimodipine is
Relevant
-
Subarachnoid Hemorrhage (Aneurysmal Subarachnoid Hemorrhage)
:
21 outcomes 42 studies in 169 results
-
Intracranial Vasospasm
:
18 outcomes 21 studies in 119 results
-
Brain Ischemia (Cerebral Ischemia)
:
15 outcomes 13 studies in 108 results
-
Stroke (Strokes)
:
11 outcomes 29 studies in 81 results
-
Ischemia
:
10 outcomes 15 studies in 112 results
Show All >>
Drugs Related to Nimodipine
-
Calcium
-
Calcium Channels (Calcium Channel)
-
Nifedipine (Adalat)
-
1,4-dihydropyridine (dihydropyridine)
-
Magnesium
-
Flunarizine
-
Nitrendipine
-
L-Type Calcium Channels (Dihydropyridine Receptor)
-
Pentylenetetrazole (Metrazol)
-
Kainic Acid (Kainate)
Show All >>
Therapies Related to Nimodipine
-
Intra-Arterial Infusions
-
Catheters
-
Oral Administration
-
Cardiopulmonary Resuscitation (CPR)
-
Traction
Show All >>
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.